Proteomic analysis of serum and urine of HIV-monoinfected and HIV/HCV-coinfected patients undergoing long term treatment with nevirapine.

MLA

Wongtrakul, Jeerang, et al. “Proteomic Analysis of Serum and Urine of HIV-Monoinfected and HIV/HCV-Coinfected Patients Undergoing Long Term Treatment with Nevirapine.” Disease Markers, vol. 2014, 2014, p. 315824. EBSCOhost, https://doi.org/10.1155/2014/315824.

APA

Wongtrakul, J., Thongtan, T., Roytrakul, S., Kumrapich, B., Janphen, K., Praparattanapan, J., Supparatpinyo, K., & Smith, D. R. (2014). Proteomic analysis of serum and urine of HIV-monoinfected and HIV/HCV-coinfected patients undergoing long term treatment with nevirapine. Disease Markers, 2014, 315824. https://doi.org/10.1155/2014/315824

Chicago

Wongtrakul, Jeerang, Thananya Thongtan, Sittiruk Roytrakul, Benjawan Kumrapich, Kanokwan Janphen, Jutarat Praparattanapan, Khuanchai Supparatpinyo, and Duncan R Smith. 2014. “Proteomic Analysis of Serum and Urine of HIV-Monoinfected and HIV/HCV-Coinfected Patients Undergoing Long Term Treatment with Nevirapine.” Disease Markers 2014: 315824. doi:10.1155/2014/315824.